[go: up one dir, main page]

CA1061251A - Methode pour eliminer des fractions proteiques les antigenes associes a l'hepatite - Google Patents

Methode pour eliminer des fractions proteiques les antigenes associes a l'hepatite

Info

Publication number
CA1061251A
CA1061251A CA166,295A CA166295A CA1061251A CA 1061251 A CA1061251 A CA 1061251A CA 166295 A CA166295 A CA 166295A CA 1061251 A CA1061251 A CA 1061251A
Authority
CA
Canada
Prior art keywords
antigen
protein
precipitate
solution
haa
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA166,295A
Other languages
English (en)
Other versions
CA166295S (en
Inventor
Alan J. Johnson
Jack Newman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UNITED STATES (THE GOVERNMENT OF THE)
Original Assignee
UNITED STATES (THE GOVERNMENT OF THE)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UNITED STATES (THE GOVERNMENT OF THE) filed Critical UNITED STATES (THE GOVERNMENT OF THE)
Application granted granted Critical
Publication of CA1061251A publication Critical patent/CA1061251A/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum
    • Y10S530/831—Cohn fractions

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CA166,295A 1972-03-16 1973-03-16 Methode pour eliminer des fractions proteiques les antigenes associes a l'hepatite Expired CA1061251A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US23521172A 1972-03-16 1972-03-16

Publications (1)

Publication Number Publication Date
CA1061251A true CA1061251A (fr) 1979-08-28

Family

ID=22884566

Family Applications (1)

Application Number Title Priority Date Filing Date
CA166,295A Expired CA1061251A (fr) 1972-03-16 1973-03-16 Methode pour eliminer des fractions proteiques les antigenes associes a l'hepatite

Country Status (8)

Country Link
US (1) US3790552A (fr)
AT (1) AT321465B (fr)
BE (1) BE796770A (fr)
CA (1) CA1061251A (fr)
DE (1) DE2306107A1 (fr)
DK (1) DK133292C (fr)
FR (1) FR2175969B1 (fr)
GB (1) GB1375811A (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3951937A (en) * 1973-12-20 1976-04-20 The Community Blood Council Of Greater New York, Inc. Large scale purification of hepatitis type B antigen using polyethylene glycol
DE2602892A1 (de) * 1976-01-27 1977-07-28 Community Blood Council Konzentriertes hepatitis-b-oberflaechenantigen enthaltende masse und verfahren zu ihrer herstellung
DK25877A (da) * 1977-01-21 1978-08-15 Nordisk Insulinlab Fremgangsmaade til udvinding af renset albumin fra blodplasma
US4197238A (en) * 1977-04-12 1980-04-08 The Green Cross Corporation Method of preparation of human albumin using polyethylene glycol
DE2750045A1 (de) * 1977-11-09 1979-05-10 Behringwerke Ag Verfahren zur entfernung von detergentien aus virusantigensuspensionen
US4164496A (en) * 1978-08-23 1979-08-14 American National Red Cross Preparation of albumin using PEG and EDTA
US4395395A (en) * 1979-05-21 1983-07-26 The United States Of America As Represented By The Department Of Health And Human Services Detection of non-A, non-B hepatitis associated antigen
FR2483779A1 (fr) * 1980-06-05 1981-12-11 Synthelabo Procede pour isoler des antigenes glycoproteiques viraux et son application a la preparation de vaccins
US4835257A (en) * 1984-07-07 1989-05-30 Armour Pharma Gmbh Process for preparing gamma globulin suitable for intravenous administration using peg and a citrate buffer
US4683294A (en) * 1985-04-03 1987-07-28 Smith Kline Rit, S.A. Process for the extraction and purification of proteins from culture media producing them
US4684723A (en) * 1985-09-11 1987-08-04 Miles Laboratories, Inc. Method of separating proteins from aqueous solutions
US4833233A (en) * 1987-08-20 1989-05-23 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Human serum albumin crystals and method of preparation
US5525519A (en) * 1992-01-07 1996-06-11 Middlesex Sciences, Inc. Method for isolating biomolecules from a biological sample with linear polymers
EP2121057A4 (fr) * 2007-02-06 2012-10-10 Incept Llc Polymérisation avec précipitation de protéines pour élution dans une solution physiologique
US20080214795A1 (en) * 2007-02-14 2008-09-04 Amgen Inc. Method of isolating antibodies by precipitation

Also Published As

Publication number Publication date
DE2306107A1 (de) 1973-09-27
US3790552A (en) 1974-02-05
DK133292B (da) 1976-04-26
DK133292C (da) 1976-09-27
GB1375811A (fr) 1974-11-27
FR2175969A1 (fr) 1973-10-26
FR2175969B1 (fr) 1977-08-12
AT321465B (de) 1975-04-10
BE796770A (fr) 1973-07-02

Similar Documents

Publication Publication Date Title
CA1061251A (fr) Methode pour eliminer des fractions proteiques les antigenes associes a l'hepatite
Ogburn et al. Purification of mouse interferon by affinity chromatography on anti-interferon globulin-sepharose
US4542016A (en) Non-a non-b hepatitis surface antigen useful for the preparation of vaccines and methods of use
US4464474A (en) Non-A, non-B hepatitis assay and vaccine
Zimmerman et al. Factor VIII coagulant activity and factor VIII-like antigen: independent molecular entities
Frommhagen et al. The role of aggregated γ-globulins in the anticomplementary activity of human and animal sera
CA1168579A (fr) Virus de l'hepatite nona - nonb
CA1212625A (fr) Methode de preparation de gammaglobulines sans hb.sub.sag et produit ainsi obtenu
EP0186360B1 (fr) Méthodes de préparation de gamma-globulines hautement purifiées, exemptes d'infectivité du virus de l'hépatite B
JPH08242849A (ja) 限外濾過によるタンパク質溶液からのウイルスの除去
US4087519A (en) Medicament for the treatment of hepatitis and/or acute or chronic infections due to the virus of hepatitis B
CA1066190A (fr) Vaccin pour immunisation active contenant l'antigene hb de (surface) et l'antigene associe a l'hepatite
US4745053A (en) Process for producing human interferon and method for assaying the interferon productivity of blood
Holland et al. Hepatitis B antigen (HB Ag) and antibody (anti‐HB Ag) in cold ethanol fractions of human plasma
Wickerhauser et al. Development of Large‐Scale Fractionation Methods: VI. An Improved Method for Preparation of Antihemophilic Factor 1
WO1981000050A1 (fr) Procede de production d'un vaccin contre l'hepatite b
James et al. Development of Large‐Scale Fractionation Methods: III. Preparation of a Factor VIII Concentrate of Intermediate‐Purity 1
WO2006107982A2 (fr) Procedes a haute resolution et reactifs de precipitation permettant d'isoler des proteines a partir de materiaux proteiques
Schwick A Survey of the Production of Plasma Derivatives
Leveque et al. HBs antigen in human plasma fractions
Wickerhauser Preparation of antihemophilic factor from indated plasma
SU728720A3 (ru) Способ получени вакцины против гепатита в
JP3158254B2 (ja) インターフェロン精製方法
Mistretta et al. Identification of some HBAg (HAA) antigenic determinants by two-dimensional electro-immunodiffusion
JPS5840930B2 (ja) Ｂ型肝炎ワクチンの製造方法